[ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management]

G Ital Nefrol. 2021 Oct 26;38(5):2021-vol5.
[Article in Italian]

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary nephropathy and is the fourth most common cause for end-stage renal disease in Europe. ADPKD is a systemic disease; besides the typical renal involvement, characterized by progressive cyst expansion leading to massive enlargement and distortion of the kidney architecture and, ultimately, to end-stage renal disease, multiple extrarenal manifestations can be observed included cysts in other organs, diverticulosis, cardiac valvulopathies, abdominal and inguinal hernias, vascular anomalies. The rupture of an intracranial aneurysm is one of the most serious complications in ADPKD patients. Aim of this review is to provide useful indications for the clinician to define the risk of intracranial aneurysms in ADPKD population, to identify screening criteria (which patients to screen, how often and with which diagnostic methods), to estimate the risk of rupture of intracranial aneurysms, which may require intervention.

Keywords: ADPKD; intracranial aneurysms; risk of rupture; screening; treatment.

Publication types

  • Review

MeSH terms

  • Follow-Up Studies
  • Humans
  • Intracranial Aneurysm* / diagnosis
  • Intracranial Aneurysm* / etiology
  • Intracranial Aneurysm* / therapy
  • Kidney
  • Kidney Failure, Chronic*
  • Polycystic Kidney, Autosomal Dominant* / diagnosis
  • Polycystic Kidney, Autosomal Dominant* / therapy